Horikoshi A, Shida M, Abe M, Hosokawa Y, Sawada S, Horie T
Department of Internal Medicine, Nihon University Nerima Hikarigaoka Hospital.
Rinsho Ketsueki. 1995 Oct;36(10):1237-9.
A 51-year-old male diagnosed as having Evans's syndrome in 1991 was treated with 25 mg of prednisolone, but his anemia and thrombocytopenia progressed. Thus, in November 1993, treatment was begun with Sairei-to, a Chinese herbal medicine consisting of several water-soluble plant extracts. Following administration of 9.0 g/day of Sairei-to granules along with prednisolone, the platelet count increased from 6.1 x 10(4)/microliters to 12.3 x 10(4)/microliters after one week, while hemoglobin levels rose from 9.5 g/dl to 12.0 g/dl after three weeks. The patient maintained a good physical condition after the prednisolone dose was reduced, although Coomb's test and PAIgG levels remained positive. Sairei-to-seems to be a promising therapeutic agent for steroid-resistant ITP and AIHA, and seems to have no side effects.
一名51岁男性于1991年被诊断为患有伊文氏综合征,曾接受25毫克泼尼松龙治疗,但贫血和血小板减少仍有进展。因此,1993年11月开始使用柴苓汤治疗,柴苓汤是一种由多种水溶性植物提取物组成的中药。在给予柴苓汤颗粒剂9.0克/天并联合泼尼松龙治疗后,血小板计数在一周后从6.1×10⁴/微升升至12.3×10⁴/微升,而血红蛋白水平在三周后从9.5克/分升升至12.0克/分升。在泼尼松龙剂量减少后,患者身体状况良好,尽管库姆斯试验和PAIgG水平仍为阳性。柴苓汤似乎是治疗激素抵抗性免疫性血小板减少症和自身免疫性溶血性贫血的一种有前景的治疗药物,且似乎没有副作用。